Guanfacine for Treatment of Attention-Deficit Hyperactivity Disorder in Boys
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The use of guanfacine hydrochloride (Tenex), a long-acting alpha2 agonist with a more favorable side effect profile relative to clonidine, was examined in boys with ADHD. In this prospective, open-label, non-blinded trial, guanfacine was prescribed to fifteen boys, aged 7 to 17 years old (mean 13.3 years) for 5-10 weeks (mean 8 weeks). Thirteen of the boys were on guanfacine monotherapy, while two were on a single adjunctive agent (with the dose of the latter unchanged during the trial). Rating scales were completed before the start of the guanfacine trial and at 4 to 8 weeks after the dose was stabilized. In general, the guanfacine appeared to be effective in reducing the target symptoms, with minimal side effects. The dose of guanfacine ranged from 0.5 mg to 3 mg daily (with a mode of 0.5 mg bid, and a mean of 1.27 mg daily). In the 13 subjects who completed the trial, the mean decrease in the Conners Parent-Teacher Scale (Short Form) was 11.1 points (t = 7.18, p < 0.0001), while the mean decrease in the Edelbrock CAP inattention subscale was 4.85 (t = 5.94, p < 0.0001) and in the overactivity subscale 3.23 (t = 5.93, p < 0.0001). Two of the patients discontinued the medication, one due to clinical ineffectiveness and one due to apparent overactivation. The findings suggest that guanfacine may be a useful agent in the management of a number of the core features of ADHD. Further studies with a double-blinded placebo-controlled design appear indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391
Clonidine in Child and Adolescent Psychiatry
HUNT, R. D., CAPPER, L., & O'CONNELL, P. (1990) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1990.1.87 · Cited by 127
Cited by
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Tourette syndrome, associated conditions and the complexities of treatment
Robertson, M. M. (2000) · Brain · doi:10.1093/brain/123.3.425 · Cited by 704
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
Metadata
- Authors
- HORRIGAN, J. P., & BARNHILL, L. J.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 1995-01
- Volume
- 5
- Issue
- 3
- Pages
- 215-223
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2039755273
- Cited by
- 117
- References
- 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.